Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

WALTHAM, Mass., Jan. 11, 2024 -- Dyne Therapeutics, Inc. , a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically...

Related Keywords

Edgewood ,New York ,United States ,San Francisco ,California ,Amy Reilly ,Raymond James ,Stacy Nartker ,Jp Morgan Securities ,Nicolaus Company Incorporated ,Morgan Stanley Co ,Morgan Stanley ,Equity Syndicate Prospectus Department ,Exchange Commission ,Nasdaq ,Oppenheimer Co ,Prospectus Department ,Broadridge Financial Solutions ,Securities Act ,Island Avenue ,One Montgomery Street ,Markets ,